WebFeb 1, 2024 · Century Therapeutics to Present at Upcoming Investor Conferences. Feb 08, 2024. Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 … WebDec 27, 2024 · This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties, and other factors, including the ability of the parties to complete or implement the transaction in a timely manner or at all; the possibility that various closing conditions ...

Century Therapeutics Announces Leadership Changes

WebOct 7, 2024 · Century Therapeutics Forward-Looking Statement This press release contains forward-looking statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private ... WebApr 12, 2024 · Dr. Levitsky previously served as Century’s President, Research and Development from 2024 until early 2024. Prior to joining the Company, he served as … s10 shock mount

Century Therapeutics Announces Leadership Changes

WebJun 1, 2024 · PHILADELPHIA, June 1, 2024 /PRNewswire/ -- Century Therapeutics, a leading cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today ... WebApr 12, 2024 · PHILADELPHIA, April 12, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the appointment of Greg Russotti, Ph.D., as ad-interim Chief Executive Officer, effective … WebJun 17, 2024 · PHILADELPHIA, June 17, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics, an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced the pricing of its initial public offering of 10,550,000 shares of its common stock at a public offering price … s10 shop